Deerfield Management’s CAS Medical Systems, Inc. CASM Stock Holding History

Deerfield Management’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,798,434	Closed	-$2.61M	–	108
2017 Q1	$2.61M	Sell	1,798,434 -1,401,566	-44%	-$2.13M	0.1%	97
2016 Q4	$5.15M	Hold	3,200,000	–	–	0.21%	76
2016 Q3	$5.53M	Hold	3,200,000	–	–	0.26%	60
2016 Q2	$5.89M	Hold	3,200,000	–	–	0.23%	67
2016 Q1	$4.54M	Hold	3,200,000	–	–	0.19%	75
2015 Q4	$5.66M	Hold	3,200,000	–	–	0.23%	77
2015 Q3	$4M	Hold	3,200,000	–	–	0.15%	97
2015 Q2	$4.1M	Hold	3,200,000	–	–	0.14%	98
2015 Q1	$4.27M	Hold	3,200,000	–	–	0.14%	91
2014 Q4	$5.28M	Hold	3,200,000	–	–	0.19%	79
2014 Q3	$6.21M	Hold	3,200,000	–	–	0.23%	82
2014 Q2	$6.43M	Hold	3,200,000	–	–	0.26%	80
2014 Q1	$6.94M	Hold	3,200,000	–	–	0.28%	80
2013 Q4	$5.44M	Hold	3,200,000	–	–	0.28%	73
2013 Q3	$4.29M	Buy	+3,200,000	New	+$4.7M	0.2%	82

Other funds holding CASM

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

1CM

1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return

TCM

TD Capital Management Memphis, Tennessee $1.11B AUM 10.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Deerfield Management's CASM Position: Q2 2017 in Review

Deerfield Management sold out of CAS Medical Systems, Inc. (CASM) in Q2 2017, closing a stake of 1,798,434 shares — an estimated $2.61M sold.

Deerfield Management first reported a position in CASM in Q3 2013 and held it in 15 quarters. The position peaked at $6.94M in Q1 2014. 18 funds tracked by Wall St. Rank hold CASM as of Q2 2017.

Deerfield Management reported no remaining CAS Medical Systems, Inc. position as of Q2 2017 after selling out during the quarter.
Deerfield Management sold 1,798,434 CAS Medical Systems, Inc. shares in Q2 2017, an estimated $2.61M.
Deerfield Management first reported a position in CAS Medical Systems, Inc. in Q3 2013 and held it in 15 quarters.
Deerfield Management's CAS Medical Systems, Inc. position peaked at $6.94M in Q1 2014.
18 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2017.

Based on Deerfield Management's 13F filing for Q2 2017, filed 14 Aug 2017.